Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS-study
2020-003078-36Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefuroxime in orthopedic device-related infection (ODRI) and bacterial disease, sponsored by Aarhus University Hospital. Primary endpoint: Time above MIC in plasma and tissues. Started Jul 2020; status: completed.
02
Drugs
cefuroxime
03
Conditions
orthopedic device-related infection (ODRI)bacterial disease
Beyond the preview
Go deeper on 2020-003078-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003078-36.